Acupuncture Reduces Schizophrenia Drug Side Effects by 56%, Study Finds

A groundbreaking study from Kyung Hee University's College of Korean Medicine offers compelling scientific evidence for the efficacy of integrating traditional acupuncture with modern psychiatric care for schizophrenia patients. The research, published in the prestigious 'Asian Journal of Psychiatry,' demonstrates that acupuncture can significantly alleviate the debilitating side effects of antipsychotic medications, a common challenge in managing this complex mental health condition.

Led by Professor Jo Sung-hoon, the research team conducted a meta-analysis of 55 randomized controlled trials, encompassing over 4,256 patients. The findings are striking: patients receiving acupuncture alongside their prescribed medications experienced a remarkable 56% reduction in adverse drug reactions compared to those on medication alone. This not only points to a safer treatment regimen but also suggests a pathway to improved treatment adherence and long-term management, crucial factors in the recovery process for individuals with schizophrenia.

“

This study confirmed through large-scale data that acupuncture treatment is practically helpful in controlling schizophrenia symptoms and managing medication side effects.

The study's implications extend beyond symptom management. It highlights the potential for a more holistic and patient-centered approach to mental healthcare, one that embraces the strengths of both traditional Korean medicine and Western medical practices. The research provides a robust foundation for developing integrated treatment models that can enhance patients' overall well-being, improve social functioning, and elevate their quality of life. This is particularly relevant in South Korea, where there is a growing appreciation for and accessibility to traditional medicine.

Furthermore, the study underscores the accessibility of such integrated treatments. Schizophrenia patients in South Korea can receive benefits for Korean medical treatments, significantly reducing out-of-pocket expenses. This financial accessibility, combined with the proven therapeutic benefits, makes the prospect of pursuing combined Korean-Chinese and Western medicine treatments more feasible for a wider range of patients. Professor Jo's vision of building personalized, integrated treatment models is thus not just a medical aspiration but a practical possibility, promising a brighter future for schizophrenia care.

“

It will serve as an important scientific foundation for building patient-customized Korean-Chinese and Western integrated treatment models in the future.